NCT00063141 Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00061815 Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00057473 A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors Status COMPLETED Phase PHASE2
NCT00055419 A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00051038 Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients Status COMPLETED Phase PHASE2/PHASE3
NCT00050596 Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00050102 Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00049257 Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00048932 A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00048581 Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. Status COMPLETED Phase PHASE3
NCT00048568 A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Status COMPLETED Phase PHASE3
NCT00046345 Atazanavir for HIV Infected Individuals: An Early Access Program Status NO_LONGER_AVAILABLE Phase N/A
NCT00041470 Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial Status TERMINATED Phase PHASE1/PHASE2
NCT00039195 Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma Status COMPLETED Phase PHASE2
NCT00037089 A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT00036621 A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy Status TERMINATED Phase PHASE2
NCT00036608 A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine Status COMPLETED Phase PHASE3
NCT00035932 Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV Status COMPLETED Phase PHASE3
NCT00035789 A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen Status COMPLETED Phase PHASE3
NCT00035633 A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen Status COMPLETED Phase PHASE3